210 related articles for article (PubMed ID: 31767275)
21. Comparative Effectiveness of Surveillance Colonoscopy Intervals on Colorectal Cancer Outcomes in a National Cohort of Patients with Inflammatory Bowel Disease.
Kim HS; Hernaez R; Sansgiry S; Waljee AK; Scott FI; Lewis JD; El-Serag HB; Hou JK
Clin Gastroenterol Hepatol; 2022 Dec; 20(12):2848-2857.e2. PubMed ID: 35240331
[TBL] [Abstract][Full Text] [Related]
22. The risk of colorectal cancer in patients with inflammatory bowel diseases in Finland: a follow-up of 20 years.
Manninen P; Karvonen AL; Huhtala H; Aitola P; Hyöty M; Nieminen I; Hemminki H; Collin P
J Crohns Colitis; 2013 Dec; 7(11):e551-7. PubMed ID: 23619008
[TBL] [Abstract][Full Text] [Related]
23. Comorbidity, age, race and stage at diagnosis in colorectal cancer: a retrospective, parallel analysis of two health systems.
Zafar SY; Abernethy AP; Abbott DH; Grambow SC; Marcello JE; Herndon JE; Rowe KL; Kolimaga JT; Zullig LL; Patwardhan MB; Provenzale DT
BMC Cancer; 2008 Nov; 8():345. PubMed ID: 19032772
[TBL] [Abstract][Full Text] [Related]
24. Patterns of computed tomography surveillance in survivors of colorectal cancer at Veterans Health Administration facilities.
Sehdev A; Sherer EA; Hui SL; Wu J; Haggstrom DA
Cancer; 2017 Jun; 123(12):2338-2351. PubMed ID: 28211937
[TBL] [Abstract][Full Text] [Related]
25. Rates and characteristics of postcolonoscopy colorectal cancer in the Swedish IBD population: what are the differences from a non-IBD population?
Stjärngrim J; Ekbom A; Hammar U; Hultcrantz R; Forsberg AM
Gut; 2019 Sep; 68(9):1588-1596. PubMed ID: 30554159
[TBL] [Abstract][Full Text] [Related]
26. Nearly a Third of High-Grade Dysplasia and Colorectal Cancer Is Undetected in Patients with Inflammatory Bowel Disease.
Eluri S; Parian AM; Limketkai BN; Ha CY; Brant SR; Dudley-Brown S; Efron JE; Fang SG; Gearhart SL; Marohn MR; Meltzer SJ; Bashar S; Truta B; Montgomery EA; Lazarev MG
Dig Dis Sci; 2017 Dec; 62(12):3586-3593. PubMed ID: 28631086
[TBL] [Abstract][Full Text] [Related]
27. 5-Aminosalicylic acid therapy and the risk of colorectal cancer among patients with inflammatory bowel disease.
Terdiman JP; Steinbuch M; Blumentals WA; Ullman TA; Rubin DT
Inflamm Bowel Dis; 2007 Apr; 13(4):367-71. PubMed ID: 17206695
[TBL] [Abstract][Full Text] [Related]
28. Inflammatory Bowel Disease-Associated Colorectal Cancer Epidemiology and Outcomes: An English Population-Based Study.
Birch RJ; Burr N; Subramanian V; Tiernan JP; Hull MA; Finan P; Rose A; Rutter M; Valori R; Downing A; Morris EJA
Am J Gastroenterol; 2022 Nov; 117(11):1858-1870. PubMed ID: 36327438
[TBL] [Abstract][Full Text] [Related]
29. Outcomes of colorectal cancer resection in patients with inflammatory bowel disease: a national population-based analysis in England and Wales.
Kuryba AJ; Vallance AE; Boyle JM; Braun MS; Blake HA; van der Meulen J; Fearnhead NS; Walker K
Colorectal Dis; 2022 Aug; 24(8):965-974. PubMed ID: 35362664
[TBL] [Abstract][Full Text] [Related]
30. Risk of Early Colorectal Cancers Needs to Be Considered in Inflammatory Bowel Disease Care.
Cohen-Mekelburg S; Schneider Y; Gold S; Ghosh G; Rosenblatt R; Hajifathalian K; Scherl E; Schnoll-Sussman F; Katz P; Steinlauf A
Dig Dis Sci; 2019 Aug; 64(8):2273-2279. PubMed ID: 30815820
[TBL] [Abstract][Full Text] [Related]
31. Use of surveillance colonoscopy in medicare patients with inflammatory bowel disease prior to colorectal cancer diagnosis.
Wang YR; Cangemi JR; Loftus EV; Picco MF
Digestion; 2014; 90(1):58-62. PubMed ID: 25196002
[TBL] [Abstract][Full Text] [Related]
32. A meta-analysis of the clinicopathological characteristics and survival outcomes of inflammatory bowel disease associated colorectal cancer.
Reynolds IS; O'Toole A; Deasy J; McNamara DA; Burke JP
Int J Colorectal Dis; 2017 Apr; 32(4):443-451. PubMed ID: 28078433
[TBL] [Abstract][Full Text] [Related]
33. Colorectal cancer complicating inflammatory bowel disease: similarities and differences between Crohn's and ulcerative colitis based on three decades of experience.
Kiran RP; Khoury W; Church JM; Lavery IC; Fazio VW; Remzi FH
Ann Surg; 2010 Aug; 252(2):330-5. PubMed ID: 20622662
[TBL] [Abstract][Full Text] [Related]
34. Colorectal cancer in patients with inflammatory bowel disease.
Vagefi PA; Longo WE
Clin Colorectal Cancer; 2005 Jan; 4(5):313-9. PubMed ID: 15663834
[TBL] [Abstract][Full Text] [Related]
35. Patients' knowledge and fear of colorectal cancer risk in inflammatory bowel disease.
Lopez A; Collet-Fenetrier B; Belle A; Peyrin-Biroulet L
J Dig Dis; 2016 Jun; 17(6):383-91. PubMed ID: 27129893
[TBL] [Abstract][Full Text] [Related]
36. Chemotherapy Tolerance and Oncologic Outcomes in Patients With Colorectal Cancer With and Without Inflammatory Bowel Disease.
Axelrad J; Kriplani A; Ozbek U; Harpaz N; Colombel JF; Itzkowitz S; Holcombe RF; Ang C
Clin Colorectal Cancer; 2017 Sep; 16(3):e205-e210. PubMed ID: 27742264
[TBL] [Abstract][Full Text] [Related]
37. Outcomes from IBD-associated and non-IBD-associated colorectal cancer: a Surveillance Epidemiology and End Results Medicare study.
Gearhart SL; Nathan H; Pawlik TM; Wick E; Efron J; Shore AD
Dis Colon Rectum; 2012 Mar; 55(3):270-7. PubMed ID: 22469793
[TBL] [Abstract][Full Text] [Related]
38. High Risk of Advanced Colorectal Neoplasia in Patients With Primary Sclerosing Cholangitis Associated With Inflammatory Bowel Disease.
Shah SC; Ten Hove JR; Castaneda D; Palmela C; Mooiweer E; Colombel JF; Harpaz N; Ullman TA; van Bodegraven AA; Jansen JM; Mahmmod N; van der Meulen-de Jong AE; Ponsioen CY; van der Woude CJ; Oldenburg B; Itzkowitz SH; Torres J
Clin Gastroenterol Hepatol; 2018 Jul; 16(7):1106-1113.e3. PubMed ID: 29378311
[TBL] [Abstract][Full Text] [Related]
39. Clinical Characteristics, Associated Malignancies and Management of Primary Sclerosing Cholangitis in Inflammatory Bowel Disease Patients: A Multicentre Retrospective Cohort Study.
Guerra I; Bujanda L; Castro J; Merino O; Tosca J; Camps B; Gutiérrez A; Gordillo Ábalos J; de Castro L; Iborra M; Carbajo AY; Taxonera C; Rodríguez-Lago I; Mesonero F; de Francisco R; Gómez-Gómez GJ; Chaparro M; Tardillo CA; Rivero M; Algaba A; Martín Arranz E; Cañete F; Vicente R; Sicilia B; Antolín B; Prieto V; Márquez L; Benítez JM; Camo P; Piqueras M; Gargallo CJ; Hinojosa E; Huguet JM; Pérez Calle JL; Van Domselaar M; Rodriguez C; Calvet X; Muñoz-Villafranca C; García-Sepulcre MF; Munoz-Garrido P; Fernández-Clotet A; Gómez Irwin L; Hernández S; Guardiola J; Sempere L; González Muñoza C; Hernández V; Beltrán B; Barrio J; Alba C; Moraleja I; López-Sanromán A; Riestra S; Martínez Montiel P; Garre A; Arranz L; García MJ; Martín Arranz MD; Corsino P; Arias L; Fernández-Salazar L; Fernández-Pordomingo A; Andreu M; Iglesias E; Ber Y; Mena R; Arroyo Villarino MT; Mora M; Ruiz L; López-Serrano P; Blazquez I; Villoria A; Fernández M; Bermejo F; Banales JM; Domènech E; Gisbert JP;
J Crohns Colitis; 2019 Dec; 13(12):1492-1500. PubMed ID: 31063540
[TBL] [Abstract][Full Text] [Related]
40. Prior colorectal neoplasia is associated with increased risk of ileoanal pouch neoplasia in patients with inflammatory bowel disease.
Derikx LA; Kievit W; Drenth JP; de Jong DJ; Ponsioen CY; Oldenburg B; van der Meulen-de Jong AE; Dijkstra G; Grubben MJ; van Laarhoven CJ; Nagtegaal ID; Hoentjen F;
Gastroenterology; 2014 Jan; 146(1):119-28.e1. PubMed ID: 24076060
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
